相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
Anjali K. Bhardwaj et al.
BMC PSYCHIATRY (2018)
The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products
Nick Jikomes et al.
SCIENTIFIC REPORTS (2018)
Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population
Ashley C. Bradford et al.
JAMA INTERNAL MEDICINE (2018)
Medical Marijuana Laws May Be Associated With A Decline In The Number Of Prescriptions For Medicaid Enrollees
Ashley C. Bradford et al.
HEALTH AFFAIRS (2017)
Labeling Accuracy of Cannabidiol Extracts Sold Online
Marcel O. Bonn-Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Patterns of marijuana use among psychiatry patients with depression and its impact on recovery
Amber L. Bahorik et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
Ashleigh L. Osborne et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Kimberly A. Babson et al.
CURRENT PSYCHIATRY REPORTS (2017)
Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study
Kevin P. Hill et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD
Mallory Loflin et al.
ADDICTIVE BEHAVIORS (2017)
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
Shanna Babalonis et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
Ashley C. Bradford et al.
HEALTH AFFAIRS (2016)
Risk Factors of Prescription Opioid Overdose Among Colorado Medicaid Beneficiaries
Piyameth Dilokthornsakul et al.
JOURNAL OF PAIN (2016)
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
Raquel Linge et al.
NEUROPHARMACOLOGY (2016)
Cannabis-induced psychosis associated with high potency wax dabs
Joseph M. Pierre et al.
SCHIZOPHRENIA RESEARCH (2016)
High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
Elizabeth M. Gordon et al.
FRONTIERS IN PHARMACOLOGY (2016)
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
Philippe Lucas et al.
DRUG AND ALCOHOL REVIEW (2016)
Prevalence and Correlates of Cannabis Use in an Outpatient VA Posttraumatic Stress Disorder Clinic
Emily L. Gentes et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2016)
Training and Practices of Cannabis Dispensary Staff
Nancy A. Haug et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Traveler’s Diarrhea
Robert Steffen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
Ryan Vandrey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Marijuana Use Is Associated With Worse Outcomes in Symptom Severity and Violent Behavior in Patients With Posttraumatic Stress Disorder
Samuel T. Wilkinson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Spatiotemporal variation and social determinants of suicide in China, 2006-2012: findings from a nationally representative mortality surveillance system
S. Liu et al.
PSYCHOLOGICAL MEDICINE (2015)
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study
Rakesh Jetly et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach
Dirk W. Lachenmeier et al.
SCIENTIFIC REPORTS (2015)
A new method of cannabis ingestion: The dangers of dabs?
Mallory Loflin et al.
ADDICTIVE BEHAVIORS (2014)
Acute and Long-Term Effects of Cannabis Use: A Review
Laurent Karila et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
From Pavlov to PTSD: The extinction of conditioned fear in rodents, humans, and anxiety disorders
Michael B. VanElzakker et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2014)
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users
Marcel O. Bonn-Miller et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2014)
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
Marcus A. Bachhuber et al.
JAMA INTERNAL MEDICINE (2014)
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus
Vicky Katsidoni et al.
ADDICTION BIOLOGY (2013)
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users
Ryan Vandrey et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Cannabidiol enhances consolidation of explicit fear extinction in humans
Ravi K. Das et al.
PSYCHOPHARMACOLOGY (2013)
Prospective Investigation of the Impact of Cannabis Use Disorders on Posttraumatic Stress Disorder Symptoms Among Veterans in Residential Treatment
Marcel O. Bonn-Miller et al.
PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY (2013)
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
Elen V. Fagherazzi et al.
PSYCHOPHARMACOLOGY (2012)
Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain
Philippe Lucas
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
Improving Clinical Outcomes in Psychiatric Care With Touch-Screen Technology
Elizabeth A. Newnham et al.
PSYCHOLOGICAL SERVICES (2012)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers
Kalpana S. Paudel et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2010)
Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer
Nicholas T. Van Dam et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2010)
Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
Yanhua Ren et al.
JOURNAL OF NEUROSCIENCE (2009)
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ronald J. Ellis et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: A multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group
Florian Strasser et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The pharmacology of cannabinoid receptors and their ligands: an overview
RG Pertwee
INTERNATIONAL JOURNAL OF OBESITY (2006)
Expression of porcine epidermal growth factor in Pichia pastoris and its biology activity in early-weaned piglets
DN Lee et al.
LIFE SCIENCES (2006)
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo et al.
MEDICAL HYPOTHESES (2006)
Endocannabinoid system and stress and anxiety responses
MP Viveros et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear
JP Chhatwal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells
T Iuvone et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Relationship of Δ9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis
MA Huestis et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2004)
Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans
CL Hart et al.
PSYCHOPHARMACOLOGY (2002)
分享论文
